|Name||Santen Pharmaceutical Co., Ltd.|
|Corporate Headquarters||Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552, Japan|
(Reception desk is on the 25th Floor.)
|Paid-in Capital||8,672 million yen (as of Mar 31, 2022)|
|Number of Employees||4,315 (Consolidated) (as of Mar 31, 2022)|
|Representatives||Takeshi Ito (President & CEO)|
|Stock Exchange Listings||Tokyo (Stock code: 4536)|
|Business||Research and development, production and marketing of pharmaceuticals and medical devices|
|Offices, Laboratories and Plants|
Nara Research and Development Center, Noto Plant, Shiga Product Supply Center, 94 offices in Japan
Japan: Claire Co., Ltd., Santen business Services CO., Ltd.
International: Santen Inc. (US), Santen Oy (Finland), etc.